Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 139

1.

VEGFR2 activation mediates the pro-angiogenic activity of BMP4.

Rezzola S, Di Somma M, Corsini M, Leali D, Ravelli C, Polli VAB, Grillo E, Presta M, Mitola S.

Angiogenesis. 2019 Jul 30. doi: 10.1007/s10456-019-09676-y. [Epub ahead of print]

PMID:
31363885
2.

Vascular Endothelial Growth Factor in the Vitreous of Proliferative Diabetic Retinopathy Patients: Chasing a Hiding Prey?

Rezzola S, Nawaz MI, Cancarini A, Semeraro F, Presta M.

Diabetes Care. 2019 Jul;42(7):e105-e106. doi: 10.2337/dc18-2527. Epub 2019 May 21. No abstract available.

PMID:
31221704
3.

Atypical Chemokine Receptor 3 Generates Guidance Cues for CXCL12-Mediated Endothelial Cell Migration.

Tobia C, Chiodelli P, Barbieri A, Buraschi S, Ferrari E, Mitola S, Borsani G, Guerra J, Presta M.

Front Immunol. 2019 May 15;10:1092. doi: 10.3389/fimmu.2019.01092. eCollection 2019.

4.

Quantification of 3D Brain Microangioarchitectures in an Animal Model of Krabbe Disease.

Righi M, Belleri M, Presta M, Giacomini A.

Int J Mol Sci. 2019 May 14;20(10). pii: E2384. doi: 10.3390/ijms20102384.

5.

Circulating microRNAs and Their Role in Multiple Myeloma.

Federico C, Sacco A, Belotti A, Ribolla R, Cancelli V, Giacomini A, Ronca R, Chiarini M, Imberti L, Marini M, Rossi G, Presta M, Paiva B, Roccaro AM.

Noncoding RNA. 2019 May 2;5(2). pii: E37. doi: 10.3390/ncrna5020037. Review.

6.

Human vitreous in proliferative diabetic retinopathy: Characterization and translational implications.

Nawaz IM, Rezzola S, Cancarini A, Russo A, Costagliola C, Semeraro F, Presta M.

Prog Retin Eye Res. 2019 Apr 2. pii: S1350-9462(18)30089-2. doi: 10.1016/j.preteyeres.2019.03.002. [Epub ahead of print] Review.

PMID:
30951889
7.

Zebrafish disease models in hematology: Highlights on biological and translational impact.

Zizioli D, Mione M, Varinelli M, Malagola M, Bernardi S, Alghisi E, Borsani G, Finazzi D, Monti E, Presta M, Russo D.

Biochim Biophys Acta Mol Basis Dis. 2019 Mar 1;1865(3):620-633. doi: 10.1016/j.bbadis.2018.12.015. Epub 2018 Dec 26. Review.

PMID:
30593895
8.

Vascular amounts and dispersion of caliber-classified vessels as key parameters to quantitate 3D micro-angioarchitectures in multiple myeloma experimental tumors.

Righi M, Locatelli SL, Carlo-Stella C, Presta M, Giacomini A.

Sci Rep. 2018 Nov 30;8(1):17520. doi: 10.1038/s41598-018-35788-4.

9.

Long Pentraxin 3-Mediated Fibroblast Growth Factor Trapping Impairs Fibrosarcoma Growth.

Rodrigues PF, Matarazzo S, Maccarinelli F, Foglio E, Giacomini A, Silva Nunes JP, Presta M, Dias AAM, Ronca R.

Front Oncol. 2018 Nov 1;8:472. doi: 10.3389/fonc.2018.00472. eCollection 2018.

10.

Long Pentraxin-3 Modulates the Angiogenic Activity of Fibroblast Growth Factor-2.

Presta M, Foglio E, Churruca Schuind A, Ronca R.

Front Immunol. 2018 Oct 8;9:2327. doi: 10.3389/fimmu.2018.02327. eCollection 2018. Review.

11.

Editorial overview: Lymphatic vessels: More than a draining pipeline.

Presta M, Sozzani S.

Curr Opin Immunol. 2018 Aug;53:vii-ix. doi: 10.1016/j.coi.2018.08.004. No abstract available.

PMID:
30220353
12.

Future applications of FGF/FGFR inhibitors in cancer.

Ghedini GC, Ronca R, Presta M, Giacomini A.

Expert Rev Anticancer Ther. 2018 Sep;18(9):861-872. doi: 10.1080/14737140.2018.1491795. Epub 2018 Jul 2. Review.

PMID:
29936878
13.

Dendritic cells in inflammatory angiogenesis and lymphangiogenesis.

Bosisio D, Ronca R, Salvi V, Presta M, Sozzani S.

Curr Opin Immunol. 2018 Aug;53:180-186. doi: 10.1016/j.coi.2018.05.011. Epub 2018 Jun 4. Review.

PMID:
29879585
14.

Claudin3 is localized outside the tight junctions in human carcinomas.

Corsini M, Ravaggi A, Odicino F, Santin AD, Ravelli C, Presta M, Romani C, Mitola S.

Oncotarget. 2018 Apr 6;9(26):18446-18453. doi: 10.18632/oncotarget.24858. eCollection 2018 Apr 6.

15.

Long pentraxin 3: A novel multifaceted player in cancer.

Giacomini A, Ghedini GC, Presta M, Ronca R.

Biochim Biophys Acta Rev Cancer. 2018 Jan;1869(1):53-63. doi: 10.1016/j.bbcan.2017.11.004. Epub 2017 Nov 23. Review.

PMID:
29175552
16.

Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer.

Ronca R, Tamma R, Coltrini D, Ruggieri S, Presta M, Ribatti D.

Oncotarget. 2017 Aug 1;8(47):82583-82592. doi: 10.18632/oncotarget.19773. eCollection 2017 Oct 10.

17.

N-tert-butyloxycarbonyl-Phe-Leu-Phe-Leu-Phe (BOC2) inhibits the angiogenic activity of heparin-binding growth factors.

Nawaz IM, Chiodelli P, Rezzola S, Paganini G, Corsini M, Lodola A, Di Ianni A, Mor M, Presta M.

Angiogenesis. 2018 Feb;21(1):47-59. doi: 10.1007/s10456-017-9581-6. Epub 2017 Oct 13.

PMID:
29030736
18.

3D endothelial cell spheroid/human vitreous humor assay for the characterization of anti-angiogenic inhibitors for the treatment of proliferative diabetic retinopathy.

Rezzola S, Nawaz IM, Cancarini A, Ravelli C, Calza S, Semeraro F, Presta M.

Angiogenesis. 2017 Nov;20(4):629-640. doi: 10.1007/s10456-017-9575-4. Epub 2017 Sep 13.

PMID:
28905243
19.

Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach.

Presta M, Chiodelli P, Giacomini A, Rusnati M, Ronca R.

Pharmacol Ther. 2017 Nov;179:171-187. doi: 10.1016/j.pharmthera.2017.05.013. Epub 2017 May 28. Review.

PMID:
28564583
20.

U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis.

Caccuri F, Ronca R, Laimbacher AS, Berenzi A, Steimberg N, Campilongo F, Mazzuca P, Giacomini A, Mazzoleni G, Benetti A, Caselli E, Presta M, Di Luca D, Fraefel C, Caruso A.

Oncotarget. 2017 Jul 4;8(27):44533-44549. doi: 10.18632/oncotarget.17817.

Supplemental Content

Loading ...
Support Center